Popel AS - Search Results

1

Mechanistically detailed systems biology modeling of the HGF/Met pathway in hepatocellular carcinoma.

Jafarnejad M, Sové RJ, Danilova L, Mirando AC, Zhang Y, Yarchoan M, Tran PT, Pandey NB, Fertig EJ, Popel AS. Jafarnejad M, et al. Among authors: popel as. NPJ Syst Biol Appl. 2019 Aug 16;5:29. doi: 10.1038/s41540-019-0107-2. eCollection 2019. NPJ Syst Biol Appl. 2019. PMID: 31452933 Free PMC article.

2

Systems biology and physiome projects.

Popel AS, Hunter PJ. Popel AS, et al. Wiley Interdiscip Rev Syst Biol Med. 2009 Sep-Oct;1(2):153-158. doi: 10.1002/wsbm.67. Wiley Interdiscip Rev Syst Biol Med. 2009. PMID: 20835988 Free PMC article. No abstract available.

3

Systems biology of pro-angiogenic therapies targeting the VEGF system.

Mac Gabhann F, Qutub AA, Annex BH, Popel AS. Mac Gabhann F, et al. Among authors: popel as. Wiley Interdiscip Rev Syst Biol Med. 2010 Nov-Dec;2(6):694-707. doi: 10.1002/wsbm.92. Wiley Interdiscip Rev Syst Biol Med. 2010. PMID: 20890966 Free PMC article. Review.

4

Anti-angiogenic peptides for cancer therapeutics.

Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS. Rosca EV, et al. Among authors: popel as. Curr Pharm Biotechnol. 2011 Aug;12(8):1101-16. doi: 10.2174/138920111796117300. Curr Pharm Biotechnol. 2011. PMID: 21470139 Free PMC article. Review.

5

Novel peptide-specific quantitative structure-activity relationship (QSAR) analysis applied to collagen IV peptides with antiangiogenic activity.

Rivera CG, Rosca EV, Pandey NB, Koskimaki JE, Bader JS, Popel AS. Rivera CG, et al. Among authors: popel as. J Med Chem. 2011 Oct 13;54(19):6492-500. doi: 10.1021/jm200114f. Epub 2011 Sep 13. J Med Chem. 2011. PMID: 21866962 Free PMC article.

6

Development of a biomimetic peptide derived from collagen IV with anti-angiogenic activity in breast cancer.

Rosca EV, Koskimaki JE, Pandey NB, Wolff AC, Popel AS. Rosca EV, et al. Among authors: popel as. Cancer Biol Ther. 2011 Nov 1;12(9):808-17. doi: 10.4161/cbt.12.9.17677. Epub 2011 Nov 1. Cancer Biol Ther. 2011. PMID: 21878750 Free PMC article.

7

Small peptides derived from somatotropin domain-containing proteins inhibit blood and lymphatic endothelial cell proliferation, migration, adhesion and tube formation.

Lee E, Rosca EV, Pandey NB, Popel AS. Lee E, et al. Among authors: popel as. Int J Biochem Cell Biol. 2011 Dec;43(12):1812-21. doi: 10.1016/j.biocel.2011.08.020. Epub 2011 Sep 6. Int J Biochem Cell Biol. 2011. PMID: 21920451 Free PMC article.

8

Pharmacokinetics and pharmacodynamics of VEGF-neutralizing antibodies.

Finley SD, Engel-Stefanini MO, Imoukhuede PI, Popel AS. Finley SD, et al. Among authors: popel as. BMC Syst Biol. 2011 Nov 21;5:193. doi: 10.1186/1752-0509-5-193. BMC Syst Biol. 2011. PMID: 22104283 Free PMC article.

9

Structure-activity relationship study of collagen-derived anti-angiogenic biomimetic peptides.

Rosca EV, Koskimaki JE, Pandey NB, Tamiz AP, Popel AS. Rosca EV, et al. Among authors: popel as. Chem Biol Drug Des. 2012 Jul;80(1):27-37. doi: 10.1111/j.1747-0285.2012.01376.x. Epub 2012 Apr 27. Chem Biol Drug Des. 2012. PMID: 22405100 Free PMC article.

10

Serpin-derived peptides are antiangiogenic and suppress breast tumor xenograft growth.

Koskimaki JE, Rosca EV, Rivera CG, Lee E, Chen W, Pandey NB, Popel AS. Koskimaki JE, et al. Among authors: popel as. Transl Oncol. 2012 Apr;5(2):92-7. doi: 10.1593/tlo.11244. Epub 2012 Apr 1. Transl Oncol. 2012. PMID: 22496925 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

342 results

Search Page

Filters